Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

01-12-2020 | Care | Research article

Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe

Authors: Primrose Nyamayaro, Hetta Gouse, James Hakim, Reuben N. Robbins, Dixon Chibanda

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

HIV affects the central nervous system resulting in HIV associated neurocognitive impairment (NCI) in approximately 50% of people living with HIV. It typically affects memory, learning, working memory, fine motor skills, speed of information processing, verbal fluency and executive functioning cognitive domains. NCI can affect adherence to antiretroviral therapy (ART), employability, driving ability and activities of daily living. NCI is not routinely screened for in Zimbabwe, and the burden is not known in this setting. The objectives of this study were: 1) To determine NCI prevalence using a comprehensive neuropsychological battery at two primary health care clinics in Harare; 2) To assess the pattern of cognitive impairment across cognitive domains using a gold standard neuropsychological (NP) battery in HIV-positive patients compared to HIV-negative controls.

Methods

Inclusion criteria: 18 years or older; minimum 7 years education; no neurological or psychiatric disorders. HIV-positive participants were on ART for ≥3 months; HIV-negative participants had a confirmed HIV negative status in the past month. A comprehensive NP battery, functional assessments, demographic and medical history questionnaires were administered. The NP battery consisted of tests assessing memory, learning, working memory, fine motor skills, speed of information processing, verbal fluency and executive functioning.

Results

Two-hundred-and-thirty-one participants were recruited. Of those, 155 were HIV-positive (Female = 70%, Age M = 37.8; SD 11.2) and 76 HIV-negative (Female = 63%, Age M = 31.2; SD 9.9). HIV-positive participants were on ART for an average of 6 years. NCI was present in 49.7% HIV positive participants. Compared to HIV-negative participants, the HIV-positive group had significantly poorer scores in 5 out of 7 cognitive domains. A good level of education is negatively correlated with NCI.

Conclusions

NCI prevalence in HIV-positive population Zimbabwe is consistent with global estimates. NCI persists in adults who are on ART. Routine assessment of NCI in adults attending primary care clinics using this adapted battery is therefore important so that they are identified early and are provided the necessary interventions.
Literature
1.
go back to reference Ministry of Health and Child Care (MOHCC), Zimbabwe. Zimbabwe National and Sub-national HIV Estimates Report. 2018. Ministry of Health and Child Care (MOHCC), Zimbabwe. Zimbabwe National and Sub-national HIV Estimates Report. 2018.
2.
go back to reference Blackard JT. HIV compartmentalization: a review on a clinically important phenomenon. Curr HIV Res. 2012;10(2):133–42.CrossRefPubMed Blackard JT. HIV compartmentalization: a review on a clinically important phenomenon. Curr HIV Res. 2012;10(2):133–42.CrossRefPubMed
4.
go back to reference Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, et al. HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol. 2016;12(4):234–48.CrossRefPubMedPubMedCentral Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, et al. HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol. 2016;12(4):234–48.CrossRefPubMedPubMedCentral
5.
go back to reference Zayyad Z, Spudich S. Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND). Curr HIV/AIDS Rep. 2015;12(1):16–24.CrossRefPubMedPubMedCentral Zayyad Z, Spudich S. Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND). Curr HIV/AIDS Rep. 2015;12(1):16–24.CrossRefPubMedPubMedCentral
6.
go back to reference Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–99.PubMed Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–99.PubMed
7.
go back to reference González-Scarano F, Martín-García J. The neuropathogenesis of AIDS. Nat Rev Immunol. 2005;5(1):69–81.CrossRefPubMed González-Scarano F, Martín-García J. The neuropathogenesis of AIDS. Nat Rev Immunol. 2005;5(1):69–81.CrossRefPubMed
8.
9.
go back to reference Ministry of Health and Child Care (MOHCC), Zimbabwe. Zimbabwe Population-Based HIV Impact Assessment (ZIMPHIA) 2015–16: First Report. Harare: MOHCC; 2017. Ministry of Health and Child Care (MOHCC), Zimbabwe. Zimbabwe Population-Based HIV Impact Assessment (ZIMPHIA) 2015–16: First Report. Harare: MOHCC; 2017.
10.
go back to reference May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS. 2014 May;28(8):1193–202.CrossRefPubMed May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS. 2014 May;28(8):1193–202.CrossRefPubMed
12.
go back to reference Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology. 2010;75(23):2087–96.CrossRefPubMedPubMedCentral Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology. 2010;75(23):2087–96.CrossRefPubMedPubMedCentral
13.
go back to reference Kabuba N, Anitha Menon J, Franklin DR, Heaton RK, Hestad KA. Use of Western neuropsychological test battery in detecting HIV-associated neurocognitive disorders (HAND) in Zambia. AIDS Behav. 2017;21(6):1717–27.CrossRefPubMedPubMedCentral Kabuba N, Anitha Menon J, Franklin DR, Heaton RK, Hestad KA. Use of Western neuropsychological test battery in detecting HIV-associated neurocognitive disorders (HAND) in Zambia. AIDS Behav. 2017;21(6):1717–27.CrossRefPubMedPubMedCentral
14.
go back to reference Kelly CM, van Oosterhout JJ, Ngwalo C, Stewart RC, Benjamin L, Robertson KR, et al. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study. PLoS One. 2014;9(6):e98962.CrossRefPubMedPubMedCentral Kelly CM, van Oosterhout JJ, Ngwalo C, Stewart RC, Benjamin L, Robertson KR, et al. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study. PLoS One. 2014;9(6):e98962.CrossRefPubMedPubMedCentral
15.
go back to reference Yechoor N, Towe SL, Robertson KR, Westreich D, Nakasujja N, Meade CS. Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting. J Neuro-Oncol. 2016;22(6):808–15. Yechoor N, Towe SL, Robertson KR, Westreich D, Nakasujja N, Meade CS. Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting. J Neuro-Oncol. 2016;22(6):808–15.
16.
17.
go back to reference Marcotte TD, Heaton RK, Wolfson T, Taylor MJ, Alhassoon O, Arfaa K, et al. The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC group. J Int Neuropsychol Soc JINS. 1999;5(7):579–92.CrossRefPubMed Marcotte TD, Heaton RK, Wolfson T, Taylor MJ, Alhassoon O, Arfaa K, et al. The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC group. J Int Neuropsychol Soc JINS. 1999;5(7):579–92.CrossRefPubMed
18.
go back to reference Woods SP, Iudicello JE, Morgan EE, Verduzco M, Smith TV, Cushman C, et al. Household everyday functioning in the internet age: online shopping and banking skills are affected in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc JINS. 2017;23(7):605–15.CrossRefPubMed Woods SP, Iudicello JE, Morgan EE, Verduzco M, Smith TV, Cushman C, et al. Household everyday functioning in the internet age: online shopping and banking skills are affected in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc JINS. 2017;23(7):605–15.CrossRefPubMed
19.
go back to reference Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and Virologic failure: a meta-analysis. Medicine (Baltimore). 2016;95(15):e3361.CrossRef Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and Virologic failure: a meta-analysis. Medicine (Baltimore). 2016;95(15):e3361.CrossRef
20.
go back to reference Robertson K, Liner J, Heaton R. Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev. 2009;19(2):232–49.CrossRefPubMedPubMedCentral Robertson K, Liner J, Heaton R. Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev. 2009;19(2):232–49.CrossRefPubMedPubMedCentral
22.
23.
go back to reference Bloch M, Kamminga J, Jayewardene A, Bailey M, Carberry A, Vincent T, et al. A screening strategy for HIV-associated neurocognitive disorders that accurately identifies patients requiring neurological review. Clin Infect Dis. 2016;63(5):687–93.CrossRefPubMedPubMedCentral Bloch M, Kamminga J, Jayewardene A, Bailey M, Carberry A, Vincent T, et al. A screening strategy for HIV-associated neurocognitive disorders that accurately identifies patients requiring neurological review. Clin Infect Dis. 2016;63(5):687–93.CrossRefPubMedPubMedCentral
24.
go back to reference Nyamayaro P, Chibanda D, Robbins RN, Hakim J, Gouse H. Assessment of neurocognitive deficits in people living with HIV in sub Saharan Africa: a systematic review. Clin Neuropsychol. 2019;0(0):1–26.CrossRef Nyamayaro P, Chibanda D, Robbins RN, Hakim J, Gouse H. Assessment of neurocognitive deficits in people living with HIV in sub Saharan Africa: a systematic review. Clin Neuropsychol. 2019;0(0):1–26.CrossRef
25.
go back to reference Robertson KR, Hall CD. Assessment of neuroAIDS in the international setting. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol. 2007;2(1):105–11.CrossRef Robertson KR, Hall CD. Assessment of neuroAIDS in the international setting. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol. 2007;2(1):105–11.CrossRef
26.
go back to reference Scott, TM, Gouse H, Joska J, Thomas KGF, Henry M, Dryer A, et al. Home- versus acquired-language test performance on the Hopkins Verbal Learning Test-Revised among multilingual South Africans. Appl Neuropsychol Adult. 2018;1-8 (In press). Scott, TM, Gouse H, Joska J, Thomas KGF, Henry M, Dryer A, et al. Home- versus acquired-language test performance on the Hopkins Verbal Learning Test-Revised among multilingual South Africans. Appl Neuropsychol Adult. 2018;1-8 (In press).
27.
go back to reference Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell TB, et al. Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study A5199, the international neurological study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;55(6):868–76.CrossRef Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell TB, et al. Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study A5199, the international neurological study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;55(6):868–76.CrossRef
28.
go back to reference Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019 Jul 1;95:103208.CrossRefPubMedPubMedCentral Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019 Jul 1;95:103208.CrossRefPubMedPubMedCentral
29.
go back to reference Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.CrossRefPubMed Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.CrossRefPubMed
30.
go back to reference Lawler K, Jeremiah K, Mosepele M, Ratcliffe SJ, Cherry C, Seloilwe E, et al. Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone. Botswana PloS One. 2011;6(2):e17233.CrossRefPubMed Lawler K, Jeremiah K, Mosepele M, Ratcliffe SJ, Cherry C, Seloilwe E, et al. Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone. Botswana PloS One. 2011;6(2):e17233.CrossRefPubMed
31.
go back to reference Lafayette Instrument Company. Grooved pegboard:User’s manual. Lafayette, IN: Lafayette Instrument Company; 2003. Lafayette Instrument Company. Grooved pegboard:User’s manual. Lafayette, IN: Lafayette Instrument Company; 2003.
32.
go back to reference Strauss E, Sherman E, Spreen O. A compendium of neuropsychological tests: administration, norms, and commentary. Oxford: Oxford University Press; 2006. Strauss E, Sherman E, Spreen O. A compendium of neuropsychological tests: administration, norms, and commentary. Oxford: Oxford University Press; 2006.
33.
go back to reference Wechsler D. Wechsler adult intelligence scale—third edition (WAIS-III). San Antonio, TX: Psychological Corporation; 1997. Wechsler D. Wechsler adult intelligence scale—third edition (WAIS-III). San Antonio, TX: Psychological Corporation; 1997.
34.
go back to reference Reitan RM, Wolfson D. The Halstead Reitan neuropsychological test battery. Tempe, AZ: Neuropsychology Press; 1985. Reitan RM, Wolfson D. The Halstead Reitan neuropsychological test battery. Tempe, AZ: Neuropsychology Press; 1985.
35.
go back to reference D’Elia LF, Satz P, Uchiyama CL, White T. Color trails test™ (CTT™). Lutz: Psychological Assessment Resources Inc. - PAR Inc.; 1996. D’Elia LF, Satz P, Uchiyama CL, White T. Color trails test™ (CTT™). Lutz: Psychological Assessment Resources Inc. - PAR Inc.; 1996.
36.
go back to reference Heaton R. K and PAR Staff. Wiscinsin Card Sorting Test: Computer Version 4-Research Edition. Lutz: Psychological Assessment Resources Inc.-PAR Inc; 2008. Heaton R. K and PAR Staff. Wiscinsin Card Sorting Test: Computer Version 4-Research Edition. Lutz: Psychological Assessment Resources Inc.-PAR Inc; 2008.
37.
go back to reference Gronwall DMA. Paced auditory serial-addition task: a measure of recovery from concussion. Perceptual and motor skills. Percept Mot Skills. 1977;44:367–73.CrossRefPubMed Gronwall DMA. Paced auditory serial-addition task: a measure of recovery from concussion. Perceptual and motor skills. Percept Mot Skills. 1977;44:367–73.CrossRefPubMed
38.
go back to reference Wechsler, D. Wechsler Memory Scale-Third edition (WMS-III). San Antonio, TX: Psychological Corporation; 1997. Wechsler, D. Wechsler Memory Scale-Third edition (WMS-III). San Antonio, TX: Psychological Corporation; 1997.
39.
go back to reference Brandt J, Benedict RHB. Hopkins verbal learning test–revised™ (HVLT-R™). Psychol Assess Resour. 2001. Brandt J, Benedict RHB. Hopkins verbal learning test–revised™ (HVLT-R™). Psychol Assess Resour. 2001.
40.
go back to reference Benedict R, Brandt J. Brief Visuospatial memory test - revised (BVMT-R). Lutz: Psychological Assessment Resources Inc. - PAR Inc.; 1997. Benedict R, Brandt J. Brief Visuospatial memory test - revised (BVMT-R). Lutz: Psychological Assessment Resources Inc. - PAR Inc.; 1997.
41.
go back to reference Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Lutz Fl: Arch Clin Neuropsychol Off J Natl Acad Neuropsychol. 1999;14(2):167–77.PubMed Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Lutz Fl: Arch Clin Neuropsychol Off J Natl Acad Neuropsychol. 1999;14(2):167–77.PubMed
43.
go back to reference Eggers C, Arendt G, Hahn K, Husstedt IW, Maschke M, Neuen-Jacob E, et al. HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J Neurol. 2017;264(8):1715–27.CrossRefPubMedPubMedCentral Eggers C, Arendt G, Hahn K, Husstedt IW, Maschke M, Neuen-Jacob E, et al. HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J Neurol. 2017;264(8):1715–27.CrossRefPubMedPubMedCentral
44.
go back to reference De Francesco D, Underwood J, Post FA, Vera JH, Williams I, Boffito M, et al. Defining cognitive impairment in people-living-with-HIV: the POPPY study. BMC Infect Dis. 2016 ;16(1).[cited 2019 Sep 11] Available from: http://bmcinfectdis.biomedcentral.com/articles/https://doi.org/10.1186/s12879-016-1970-8. De Francesco D, Underwood J, Post FA, Vera JH, Williams I, Boffito M, et al. Defining cognitive impairment in people-living-with-HIV: the POPPY study. BMC Infect Dis. 2016 ;16(1).[cited 2019 Sep 11] Available from: http://​bmcinfectdis.​biomedcentral.​com/​articles/​https://​doi.​org/​10.​1186/​s12879-016-1970-8.
45.
go back to reference Kabuba N, Menon JA, Franklin DR, Lydersen S, Heaton RK, Hestad KA. Effect of age and level of education on neurocognitive impairment in HIV positive Zambian adults. Neuropsychology. 2018;32(5):519–28.CrossRefPubMedPubMedCentral Kabuba N, Menon JA, Franklin DR, Lydersen S, Heaton RK, Hestad KA. Effect of age and level of education on neurocognitive impairment in HIV positive Zambian adults. Neuropsychology. 2018;32(5):519–28.CrossRefPubMedPubMedCentral
47.
go back to reference Terpstra AR, Worthington C, Ibáñez-Carrasco F, O’Brien KK, Yamamoto A, Chan Carusone S, et al. “I’m just forgetting and I Don’t know why”: exploring how people living with HIV-associated neurocognitive disorder view, manage, and obtain support for their cognitive difficulties. Qual Health Res. 2018;28(6):859–72.CrossRefPubMed Terpstra AR, Worthington C, Ibáñez-Carrasco F, O’Brien KK, Yamamoto A, Chan Carusone S, et al. “I’m just forgetting and I Don’t know why”: exploring how people living with HIV-associated neurocognitive disorder view, manage, and obtain support for their cognitive difficulties. Qual Health Res. 2018;28(6):859–72.CrossRefPubMed
48.
go back to reference Ma Q, Vaida F, Wong J, Sanders CA, Kao Y, Croteau D, et al. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neuro-Oncol. 2016;22(2):170–8. Ma Q, Vaida F, Wong J, Sanders CA, Kao Y, Croteau D, et al. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neuro-Oncol. 2016;22(2):170–8.
49.
go back to reference Nightingale S, Winston A. Measuring and managing cognitive impairment in HIV. AIDS. 2017;31:S165–72.CrossRefPubMed Nightingale S, Winston A. Measuring and managing cognitive impairment in HIV. AIDS. 2017;31:S165–72.CrossRefPubMed
50.
go back to reference World Health Organisation. WHO recommends dolutegravir as preferred HIV treatment option in all populations. Mexico: World Health Organisation; 2019. World Health Organisation. WHO recommends dolutegravir as preferred HIV treatment option in all populations. Mexico: World Health Organisation; 2019.
Metadata
Title
Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe
Authors
Primrose Nyamayaro
Hetta Gouse
James Hakim
Reuben N. Robbins
Dixon Chibanda
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05090-8

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue